Registered clinical trials for immunotherapy in esophageal cancer (IMAGE)

Cactus Communications

Registered clinical trials for immunotherapy in esophageal cancer

Caption

Multiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could cement ICI-based immunotherapy as the new standard systemic treatment option for esophageal cancer.

Credit

Hecheng Li of Department of Thoracic Surgery, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Usage Restrictions

Attribution is required

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.